Bio Essence Corp (BIOE)
D
Pipeline Grade
Financial Position (from SEC Filings)
$0.0M
Cash & Equivalents
$0.4M
Quarterly Burn Rate
$13M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (2)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06902181 | Observation of Inhalation of CXMCI-01 Essential Oil on Patients With Mild Cognitive Impairment | OTHER | Recruiting | 100 |
| NCT06321965 | Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy | OTHER | Recruiting | 60 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.